149 related articles for article (PubMed ID: 34308441)
1. Vascular Endothelial Growth Factor Receptor Expression in Orbital Cavernous Malformations and Lymphatic Malformations.
Tran AQ; Shoji MK; Levitt A; Lee WW
Ophthalmol Vis Care; 2021; 1(1):. PubMed ID: 34308441
[TBL] [Abstract][Full Text] [Related]
2. Expression of Vascular Endothelial Growth Factor Receptors in Benign Vascular Lesions of the Orbit: A Case Series.
Atchison EA; Garrity JA; Castillo F; Engman SJ; Couch SM; Salomão DR
Ophthalmology; 2016 Jan; 123(1):209-13. PubMed ID: 26481818
[TBL] [Abstract][Full Text] [Related]
3. Orbital venous-lymphatic malformations (lymphangiomas) mimicking cavernous hemangiomas.
Selva D; Strianese D; Bonavolonta G; Rootman J
Am J Ophthalmol; 2001 Mar; 131(3):364-70. PubMed ID: 11239871
[TBL] [Abstract][Full Text] [Related]
4. VEGF-C and VEGFR-3 in a series of lymphangiomas: is superficial lymphangioma a true lymphangioma?
Itakura E; Yamamoto H; Oda Y; Furue M; Tsuneyoshi M
Virchows Arch; 2009 Mar; 454(3):317-25. PubMed ID: 19151999
[TBL] [Abstract][Full Text] [Related]
5. Orbital lymphangioma with positive immunohistochemistry of lymphatic endothelial markers (vascular endothelial growth factor receptor 3 and podoplanin).
Cursiefen C; Schlötzer-Schrehardt U; Breiteneder-Geleff S; Holbach LM
Graefes Arch Clin Exp Ophthalmol; 2001 Aug; 239(8):628-32. PubMed ID: 11585321
[TBL] [Abstract][Full Text] [Related]
6. Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease: An Analysis of Vascular Growth Factors with Clinical Correlation.
Wong LL; Lee NG; Amarnani D; Choi CJ; Bielenberg DR; Freitag SK; D'Amore PA; Kim LA
Ophthalmology; 2016 Sep; 123(9):2028-36. PubMed ID: 27423310
[TBL] [Abstract][Full Text] [Related]
7. Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma.
Holzer TR; Fulford AD; Reising LO; Nedderman DM; Zhang X; Benjamin LE; Schade AE; Nasir A
Anticancer Res; 2016 Jul; 36(7):3277-88. PubMed ID: 27354584
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.
Nasir A; Reising LO; Nedderman DM; Fulford AD; Uhlik MT; Benjamin LE; Schade AE; Holzer TR
Anticancer Res; 2016 Jun; 36(6):2683-96. PubMed ID: 27272777
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
10. Cavernous venous malformations of the orbit (so-called cavernous haemangioma): a comprehensive evaluation of their clinical, imaging and histologic nature.
Rootman DB; Heran MK; Rootman J; White VA; Luemsamran P; Yucel YH
Br J Ophthalmol; 2014 Jul; 98(7):880-8. PubMed ID: 24627253
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of cavernous hemangioma and other vascular malformations of the orbit. A report of three cases.
Strianese D; Napoli M; Russo C; D'Errico A; Scotti N; Puoti G; Bonavolontà G; Tranfa F; Briganti F
Neuroradiol J; 2014 Apr; 27(2):223-31. PubMed ID: 24750713
[TBL] [Abstract][Full Text] [Related]
12. [The expression and significance of structural proteins, VEGF and Ang-1 in cavernous venous malformations of the body surface].
Ouyang TX; Yuan SM; Xing X; Ni CR; Zheng WQ; Wen P
Zhonghua Zheng Xing Wai Ke Za Zhi; 2003 Jan; 19(1):47-50. PubMed ID: 12778797
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
15. Orbital lymphaticovenous malformations: Current and future treatments.
Nassiri N; Rootman J; Rootman DB; Goldberg RA
Surv Ophthalmol; 2015; 60(5):383-405. PubMed ID: 26077629
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
17. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
18. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
Shoji MK; Shishido S; Freitag SK
Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
[TBL] [Abstract][Full Text] [Related]
19. Growth potential of orbital cavernous hemangioma suggested by vascular endothelial growth factor and its receptor flk-1.
Nagasaka M; Naganuma H; Satoh E
Neurol Med Chir (Tokyo); 2007 Jan; 47(1):5-10. PubMed ID: 17245007
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos.
Hiratsuka S; Kataoka Y; Nakao K; Nakamura K; Morikawa S; Tanaka S; Katsuki M; Maru Y; Shibuya M
Mol Cell Biol; 2005 Jan; 25(1):355-63. PubMed ID: 15601856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
